Detalles de la búsqueda
1.
The relationship among posttraumatic stress disorder, posttraumatic growth, and suicidal ideation among Italian healthcare workers during the first wave of COVID-19 pandemic.
CNS Spectr
; 29(1): 60-64, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37753729
2.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
N Engl J Med
; 381(17): 1632-1643, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566309
3.
Complete pathological response of colorectal peritoneal metastases in Lynch syndrome after immunotherapy case report: is a paradigm shift in cytoreductive surgery needed?
BMC Gastroenterol
; 22(1): 17, 2022 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012456
4.
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
Int J Mol Sci
; 23(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36232827
5.
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 22(6): 779-789, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961795
6.
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
Mod Pathol
; 34(8): 1547-1557, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33714983
7.
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer.
Pharmacogenomics J
; 21(3): 285-295, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33542444
8.
Transitioning from second-line to third-line therapy in metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 19 Suppl 3(1): 1-20, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33843898
9.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
10.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270478
11.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424148
12.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369650
13.
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
Oncologist
; 25(6): 481-487, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31967692
14.
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.
Cancer Cell Int
; 20: 30, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015690
15.
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Gastric Cancer
; 23(6): 1064-1074, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372141
16.
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.
Int J Cancer
; 145(8): 2082-2090, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30856283
17.
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
Br J Cancer
; 121(3): 257-263, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235864
18.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474758
19.
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?
Oncologist
; 24(2): e77-e79, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120156
20.
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib.
Pharmacogenomics J
; 19(5): 455-464, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30686821